Outcome of the Board Meeting held on 12.11.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Tuticorin Alkali Chemicals approved the unaudited financial results for the quarter and six months ended 30 September 2025. Revenue from operations grew to Rs. 15,614.11 lakhs in H1 FY26 from Rs. 14,673.33 lakhs in H1 FY25, a rise of about 6.4%. Standalone Q2 revenue rose to Rs. 7,999.20 lakhs from Rs. 7,441.82 lakhs. Profit after tax for H1 FY26 stood at Rs. 1,944.08 lakhs (EPS Rs. 1.60), compared to Rs. 5,005.95 lakhs in the prior year period which was boosted by an exceptional insurance claim of Rs. 2,287.81 lakhs related to December 2023 flood losses. Operating cash flow swung strongly positive to Rs. 6,373.52 lakhs from a negative Rs. 1,219.77 lakhs earlier. The company continues to invest in capex (Rs. 4,447.05 lakhs in H1) and its reserves remain negative at Rs. (17,955.86) lakhs due to accumulated past losses. The statutory auditor MSKA & Associates issued an unqualified limited review report.
Core operations are improving with revenue growth, a strong turnaround in operating cash flow, and ongoing capacity expansion. However, headline PAT fell sharply mainly because the prior period had a one-time insurance gain, and the negative reserves position remains a structural concern. For shareholders, the stock is likely to be driven by capex progress and margin trajectory rather than near-term profit comparisons.